Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: October 18, 2024 Report Code: GDME1865EPD-ST

Select Item

Infusion Pumps Pipeline Market Report Overview

An infusion pump is a medical device, used to administer controlled amounts of therapeutic fluids including nutrients or medication into a patient’s body. It can deliver medication continuously, intermittently, or on a patient-controlled on-demand basis. Infusion pumps can be classified into various categories based on function, volume, and mobility. The infusion pumps pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Europe

·       Singapore

·       Israel

·       Japan
Key Regulatory Paths ·       510(k)

·       HSA

·       CE

·       Ninsho
Leading Companies ·       AbbVie Inc

·       Acuros GmbH

·       Avoset Health Ltd

·       Baxter International Inc

·       Fresenius Medical Care AG & Co KGaA
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Infusion Pumps Pipeline Market Segmentation by Territories

 The key territories associated with the infusion pumps pipeline market are Europe, the United States, Singapore, Japan, and Israel. As of October 2024, the US had the highest number of infusion pumps pipeline products.

Infusion Pumps Pipeline Market Analysis by Territories, 2024 (%)

Infusion Pumps Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Infusion Pumps Pipeline Market

Download a Free Report Sample

Infusion Pumps Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the infusion pumps pipeline products market are CE, Ninsho, HSA, and 510(k). As of October 2024, 510(k) was the most followed pathway for pipeline products in the infusion pumps market.

Infusion Pumps Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Infusion Pumps Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Infusion Pumps Pipeline Market

Download a Free Report Sample

Infusion Pumps Pipeline Market – Competitive Landscape

A few of the key companies associated with the infusion pumps pipeline market are AbbVie Inc, Acuros GmbH, Avoset Health Ltd, Baxter International Inc, and Fresenius Medical Care AG & Co KGaA among others.

AbbVie Inc (AbbVie): AbbVie Inc (AbbVie) is a specialty biopharmaceutical company, which discovers, develops, manufactures, and commercializes drugs for the treatment of chronic and complex diseases. Its drugs are indicated for the treatment of metabolic and rheumatological diseases, neurological disorders, skin diseases, rheumatoid arthritis, pain related to endometriosis, pediatric Crohn’s disease, cancer, and other serious health conditions.

Acuros GmbH (Acuros): Acuros GmbH (Acuros) is a medical device company that develops osmotic micropumps for medical and microfluidic applications. The company’s products include disposable micropumps, precision micropumps, and extensometer. It offers extensometer for measuring growth of plant compounds in a flow cuvette for research and educational experiments.

Infusion Pumps Pipeline Market Analysis by Companies, As of October 2024
Infusion Pumps Pipeline Market Analysis by Companies, As of October 2024 Buy the Full Report for More Company Insights into the Infusion Pumps Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Infusion Pumps Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • Singapore
  • Israel
  • Japan

Infusion Pumps Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • NMPA
  • CE
  • Ninsho

Scope

  • Extensive coverage of the infusion pumps under development.

  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities.

  • The report reviews the major players involved in the development of infusion pumps and list all their pipeline projects.

  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage.

  • The report provides key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment / industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with the potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of infusion pumps under development.

  • Develop market-entry and market expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

AbbVie Inc
Acuros GmbH
Avoset Health Ltd
Baxter International Inc
ClearLine MD (Inactive)
Fluonic, Inc. (Inactive)
Fresenius Medical Care AG & Co KGaA
Gerresheimer AG
Hospira Inc
Innovfusion Pte. Ltd.
IRadimed Corp
KORU Medical Systems Inc
Liquidia Corp
Lynntech Inc
Massachusetts Institute of Technology
Medical Device Creations Ltd.
Palyon Medical Corp (Inactive)
Shift Labs Inc
StnDrd Infusion Corporation
Supernus Pharmaceuticals Inc
Terumo Corp
Turnpoint Medical Devices Inc
United Therapeutics Corp

Table of Contents

  • 1 Table of Contents

  • 1.1 List of Tables

  • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Infusion Pumps Overview

  • 3 Products under Development

    • 3.1 Infusion Pumps – Pipeline Products by Stage of Development

    • 3.2 Infusion Pumps – Pipeline Products by Territory

    • 3.3 Infusion Pumps – Pipeline Products by Regulatory Path

    • 3.4 Infusion Pumps – Pipeline Products by Estimated Approval Date

    • 3.5 Infusion Pumps – Ongoing Clinical Trials

  • 4 Infusion Pumps – Pipeline Products under Development by Companies

    • 4.1 Infusion Pumps Companies – Pipeline Products by Stage of Development

    • 4.2 Infusion Pumps – Pipeline Products by Stage of Development

  • 5 Infusion Pumps Companies and Product Overview

    • 5.1 AbbVie Inc Company Overview

      • 5.1.1 AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Acuros GmbH Company Overview

      • 5.2.1 Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Avoset Health Ltd Company Overview

      • 5.3.1 Avoset Health Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Baxter International Inc Company Overview

      • 5.4.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 ClearLine MD (Inactive) Company Overview

      • 5.5.1 ClearLine MD (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Fluonic, Inc. (Inactive) Company Overview

      • 5.6.1 Fluonic, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Fresenius Medical Care AG & Co KGaA Company Overview

      • 5.7.1 Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Gerresheimer AG Company Overview

      • 5.8.1 Gerresheimer AG Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Hospira Inc Company Overview

      • 5.9.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Innovfusion Pte. Ltd. Company Overview

      • 5.10.1 Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 IRadimed Corp Company Overview

      • 5.11.1 IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 KORU Medical Systems Inc Company Overview

      • 5.12.1 KORU Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Liquidia Corp Company Overview

      • 5.13.1 Liquidia Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Lynntech Inc Company Overview

      • 5.14.1 Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Massachusetts Institute of Technology Company Overview

      • 5.15.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Medical Device Creations Ltd. Company Overview

      • 5.16.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Palyon Medical Corp (Inactive) Company Overview

      • 5.17.1 Palyon Medical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Shift Labs Inc Company Overview

      • 5.18.1 Shift Labs Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 StnDrd Infusion Corporation Company Overview

      • 5.19.1 StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Supernus Pharmaceuticals Inc Company Overview

      • 5.20.1 Supernus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Terumo Corp Company Overview

      • 5.21.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 Turnpoint Medical Devices Inc Company Overview

      • 5.22.1 Turnpoint Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 United Therapeutics Corp Company Overview

      • 5.23.1 United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Infusion Pumps- Recent Developments

    • 6.1 Aug 06, 2024: Innovative Health Sciences to market syringe infusion system

    • 6.2 Aug 02, 2024: Moog Announces Q3 2024 Results

    • 6.3 Jul 25, 2024: IRADIMED to Hold 2024 Second Quarter Financial Results Conference Call on August 1st

    • 6.4 Jun 25, 2024: United Therapeutics Receives Additional 510(K) Clearance For RemUnity System

    • 6.5 May 02, 2024: IRadimed Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share

    • 6.6 May 02, 2024: ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore

    • 6.7 Apr 27, 2024: Moog Reports Results for the Quarter Ended in March – Earnings Summary

    • 6.8 Apr 08, 2024: Supernus Provides Regulatory Update for SPN-830

    • 6.9 Mar 11, 2024: Innovative Health Sciences Receives FDA 510(k) Clearance for Insignis Syringe Infusion System

    • 6.10 Mar 11, 2024: DEKA Research and Development Receives FDA 510(k) Clearance for Infusion System

    • 6.11 Mar 06, 2024: KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

    • 6.12 Mar 05, 2024: Smiths Medical Recalls Medfusion Model 3500 Syringe Pump Due to Issues Associated with Earlier Software Versions

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer

Table

Infusion Pumps – Pipeline Products by Stage of Development

Infusion Pumps – Pipeline Products by Territory

Infusion Pumps – Pipeline Products by Regulatory Path

Infusion Pumps – Pipeline Products by Estimated Approval Date

Infusion Pumps – Ongoing Clinical Trials

Infusion Pumps Companies – Pipeline Products by Stage of Development

Infusion Pumps – Pipeline Products by Stage of Development

AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview

Vyafuser Pump – Product Status

Vyafuser Pump – Product Description

Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview

Disposable Micropump – Product Status

Disposable Micropump – Product Description

Avoset Health Ltd Pipeline Products & Ongoing Clinical Trials Overview

AvosetGo Connected Infusion Pump – Product Status

AvosetGo Connected Infusion Pump – Product Description

Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview

Vita IQ – Product Status

Vita IQ – Product Description

ClearLine MD (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

FloStat Infusion Pump System – Product Status

FloStat Infusion Pump System – Product Description

Fluonic, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

SURE+ – Product Status

SURE+ – Product Description

Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview

Intravenous 2008MeDS – Product Status

Intravenous 2008MeDS – Product Description

Gerresheimer AG Pipeline Products & Ongoing Clinical Trials Overview

SenseFlex 20ml – Product Status

SenseFlex 20ml – Product Description

Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview

Lifecare PCA Restart – Product Status

Lifecare PCA Restart – Product Description

Smart Infusion Pump Integrated With Accelero Connect Software – Product Status

Smart Infusion Pump Integrated With Accelero Connect Software – Product Description

Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview

DIVA – Product Status

DIVA – Product Description

EPIVA – Product Status

EPIVA – Product Description

INTRAVA – Product Status

INTRAVA – Product Description

IRadimed Corp Pipeline Products & Ongoing Clinical Trials Overview

MRidium 3870 Infusion Pump System – Product Status

MRidium 3870 Infusion Pump System – Product Description

KORU Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

Next – Generation Subcutaneous Immunoglobulin Infusion System – Product Status

Next – Generation Subcutaneous Immunoglobulin Infusion System – Product Description

KORU Medical Systems Inc – Ongoing Clinical Trials Overview

Next – Generation Subcutaneous Immunoglobulin Infusion System – A Study to Evaluate the Safety, Efficacy, and Performance of the SCIg Drug in the Treatment of Autoimmune Diseases, Primary Immunodeficiency Disorders, and Neurological Disorders

Liquidia Corp Pipeline Products & Ongoing Clinical Trials Overview

Treprostinil Subcutaneous Infusion Pump – Product Status

Treprostinil Subcutaneous Infusion Pump – Product Description

Lynntech Inc Pipeline Products & Ongoing Clinical Trials Overview

TRIAD-MP Drug Infusion Pump – Product Status

TRIAD-MP Drug Infusion Pump – Product Description

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview

Compact Self-Powered Actuator – Product Status

Compact Self-Powered Actuator – Product Description

Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Infusion Pump – Product Status

Infusion Pump – Product Description

Palyon Medical Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Palyon Implantable Drug Delivery System – Product Status

Palyon Implantable Drug Delivery System – Product Description

Shift Labs Inc Pipeline Products & Ongoing Clinical Trials Overview

DripAssist Control – Product Status

DripAssist Control – Product Description

StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview

StnDrd Infusion Pump – Product Status

StnDrd Infusion Pump – Product Description

Supernus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview

SPN-830 – Product Status

SPN-830 – Product Description

Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview

Infusion Pump – Product Status

Infusion Pump – Product Description

Turnpoint Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

Breeze Infusion Pump – Product Status

Breeze Infusion Pump – Product Description

United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview

Trevyent – Product Status

Trevyent – Product Description

Glossary

Figures

Infusion Pumps – Pipeline Products by Stage of Development

Infusion Pumps – Pipeline Products by Territory

Infusion Pumps – Pipeline Products by Regulatory Path

Infusion Pumps – Pipeline Products by Estimated Approval Date

Infusion Pumps – Ongoing Clinical Trials

Frequently asked questions

Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Infusion Pumps reports
Medical Devices
New
Neurovascular Accessory Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Medical Devices
New
Neurovascular Embolization Devices Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Medical Devices
New
Sutures Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more